SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Cars.com
CARS
Hutchmed (China)
HCM
Halozyme Therapeutics
HALO
(Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 58.12%54.39M | 149.98%188.76M | 70.58%58.36M | 376.30%53.95M | 205.69%42.05M | 34.4M | 27.90%75.51M | 175.40%34.22M | -25.37%11.33M | -31.73%13.76M |
Operating revenue | 53.40%52.76M | 147.91%187.19M | 66.00%56.8M | 376.30%53.95M | 205.69%42.05M | --34.4M | 27.90%75.51M | 175.40%34.22M | -25.37%11.33M | -31.73%13.76M |
Cost of revenue | 84.85%7.72M | 24.06%22.2M | 38.47%9.36M | 75.43%4.33M | 6.64%4.33M | 4.18M | 140.29%17.9M | 96.54%6.76M | 69.87%2.47M | 210.23%4.06M |
Gross profit | 54.43%46.67M | 189.10%166.56M | 78.49%49.01M | 460.20%49.62M | 289.15%37.71M | 30.22M | 11.67%57.61M | 205.58%27.46M | -35.46%8.86M | -48.55%9.69M |
Operating expense | 111.75%85.81M | 82.65%193.71M | 87.67%69.64M | 126.59%42.99M | 47.35%40.42M | 40.53M | 107.44%106.06M | 96.51%37.11M | 51.27%18.97M | 106.59%27.43M |
Selling and administrative expenses | 55.54%14.57M | 57.59%42.6M | 50.23%19.04M | 69.59%7.84M | 85.31%12.03M | --9.37M | 3.67%27.03M | 66.36%12.67M | -27.71%4.62M | -24.01%6.49M |
-Selling and marketing expense | 97.27%578K | 186.45%2.05M | ---- | ---- | 305.05%401K | --293K | 134.75%716K | ---- | ---- | 52.31%99K |
-General and administrative expense | 54.19%13.99M | 54.08%40.55M | 42.07%16.99M | 69.59%7.84M | 81.91%11.62M | --9.07M | 2.12%26.31M | 57.61%11.96M | -26.11%4.62M | -24.59%6.39M |
Depreciation amortization depletion | 346.31%34.01M | 64.15%50.65M | 297.68%26.78M | 69.60%8.69M | -34.53%7.56M | --7.62M | 298.60%30.86M | 96.55%6.73M | 124.15%5.13M | 815.46%11.54M |
-Depreciation and amortization | 346.31%34.01M | 64.15%50.65M | 297.68%26.78M | 69.60%8.69M | -34.53%7.56M | --7.62M | 298.60%30.86M | 96.55%6.73M | 124.15%5.13M | 815.46%11.54M |
Other taxes | 91.51%3.65M | 43.81%7.68M | ---- | ---- | 214.02%1.68M | --1.91M | 116.40%5.34M | ---- | ---- | --535K |
Other operating expenses | 55.24%33.58M | 116.63%92.78M | 30.58%16.14M | 186.78%26.47M | 116.16%19.15M | --21.63M | 188.53%42.83M | 130.11%12.36M | 138.74%9.23M | 154.85%8.86M |
Operating profit | -279.84%-39.14M | 43.94%-27.16M | -113.80%-20.63M | 165.46%6.62M | 84.76%-2.7M | -10.31M | -10,586.15%-48.45M | 2.50%-9.65M | -956.58%-10.12M | -419.03%-17.74M |
Net non-operating interest income expense | 227.35%2.23M | 136.13%5.58M | 775.76%2.89M | 166.47%1.37M | 106.29%635K | 680K | 55.40%-15.44M | 117.14%330K | -45.30%-2.07M | 33.64%-10.09M |
Non-operating interest income | 221.04%2.29M | 531.06%5.83M | 533.69%2.95M | 514.75%1.5M | 158.75%665K | --713K | 1,069.62%924K | 595.51%466K | 1,933.60%244K | --257K |
Non-operating interest expense | 90.91%63K | -98.35%253K | 106.98%63K | -94.55%126K | -99.71%30K | --33K | -52.39%15.33M | -155.26%-902K | 101.95%2.31M | -26.14%10.35M |
Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | -58.61%1.04M | ---- | ---- | ---- |
Other net income (expense) | -362.57%-13.51M | 96.28%-3.92M | -473.37%-9.1M | -56.47%4.11M | 96.38%-4.22M | 5.15M | 72.42%-105.6M | -91.63%2.44M | 268.01%9.45M | -240.19%-116.53M |
Gain on sale of security | -157.34%-3.03M | -2,032.98%-4.07M | -437.73%-8.2M | -18.50%3.71M | 21.86%-4.86M | --5.28M | 99.95%-191K | -91.53%2.43M | 178.11%4.56M | -107.49%-6.23M |
Special income (charges) | -104,200.00%-10.41M | 100.14%151K | 345.45%27K | -99.97%1K | 100.10%113K | --10K | -64,895.21%-108.54M | -543.99%-11K | 1,476.29%3.1M | ---110.31M |
-Less:Impairment of capital assets | ---- | -100.10%-108K | --0 | --0 | ---108K | ---- | --104.09M | --104.09M | --0 | --0 |
-Less:Other special charges | --1.72M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Write off | --9.52M | --0 | --0 | --0 | --0 | --0 | 549.10%1.08M | -4,201,156.99%-104.09M | --0 | --105.17M |
-Gain on sale of business | ---- | --0 | --0 | --0 | ---- | ---- | --3.26M | --1K | --3.26M | ---- |
-Gain on sale of property,plant,equipment | 8,280.00%838K | 100.65%43K | 325.00%27K | 100.63%1K | 100.10%5K | --10K | ---6.63M | ---12K | ---160K | ---5.14M |
Other non- operating income (expenses) | 47.52%-74K | ---- | ---- | -77.81%399K | --527K | ---141K | 26,041.67%3.14M | -95.63%20K | 14,885.32%1.8M | ---- |
Income before tax | -1,025.56%-50.43M | 84.95%-25.5M | -289.96%-26.84M | 543.30%12.11M | 95.64%-6.29M | -4.48M | 59.36%-169.48M | -139.81%-6.88M | 53.44%-2.73M | -296.48%-144.37M |
Income tax | 56.15%1.28M | 44.48%3.45M | 448.78%225K | 981.93%3.47M | -159.12%-1.07M | 821K | -12.26%2.39M | 107.78%41K | 110.07%321K | -113.04%-411K |
Net income | -875.42%-51.71M | 83.15%-28.96M | -290.90%-27.07M | 382.93%8.64M | 96.37%-5.23M | -5.3M | 59.06%-171.87M | -138.86%-6.92M | -13.98%-3.05M | -304.70%-143.95M |
Net income continuous Operations | -875.42%-51.71M | 83.15%-28.96M | -290.90%-27.07M | 382.93%8.64M | 96.37%-5.23M | ---5.3M | 59.06%-171.87M | -138.86%-6.92M | -13.98%-3.05M | -304.70%-143.95M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -875.42%-51.71M | 83.15%-28.96M | -290.90%-27.07M | 382.93%8.64M | 96.37%-5.23M | -5.3M | 59.06%-171.87M | -138.86%-6.92M | -13.98%-3.05M | -304.70%-143.95M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -875.42%-51.71M | 83.15%-28.96M | -290.90%-27.07M | 382.93%8.64M | 96.37%-5.23M | -5.3M | 59.06%-171.87M | -138.86%-6.92M | -13.98%-3.05M | -304.70%-143.95M |
Basic earnings per share | -237.50%-0.27 | 90.76%-0.29 | -265.82%-0.1452 | 245.09%0.0827 | 97.35%-0.072 | -0.08 | 69.37%-3.14 | -102.48%-0.0397 | -12.78%-0.057 | -242.76%-2.7146 |
Diluted earnings per share | -237.50%-0.27 | 90.76%-0.29 | -265.82%-0.1452 | 235.09%0.077 | 97.35%-0.072 | -0.08 | 69.37%-3.14 | -102.48%-0.0397 | -12.78%-0.057 | -497.69%-2.7146 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |